RFX-B is the gene responsible for the most common cause of the bare lymphocyte syndrome, an MHC class II immunodeficiency
- PMID: 10072068
- DOI: 10.1016/s1074-7613(00)80016-3
RFX-B is the gene responsible for the most common cause of the bare lymphocyte syndrome, an MHC class II immunodeficiency
Erratum in
- Immunity 1999 Mar;10(3):399
Abstract
The bare lymphocyte syndrome (BLS) is characterized by the absence of MHC class II transcription and humoral- and cellular-mediated immune responses to foreign antigens. Three of the four BLS genetic complementation groups have defects in the activity of the MHC class II transcription factor RFX. We have purified the RFX complex and sequenced its three subunits. The sequence of the smallest subunit describes a novel gene, termed RFX-B. RFX-B complements the predominant BLS complementation group (group B) and was found to be mutant in cell lines from this BLS group. The protein has no known DNA-binding domain but does contain three ankyrin repeats that are likely to be important in protein-protein interactions.
Similar articles
-
Evolutionary conservation and characterization of the bare lymphocyte syndrome transcription factor RFX-B and its paralogue ANKRA2.Immunogenetics. 2005 Feb;56(11):788-97. doi: 10.1007/s00251-004-0738-2. Epub 2005 Jan 18. Immunogenetics. 2005. PMID: 15655668
-
Conserved residues of the bare lymphocyte syndrome transcription factor RFXAP determine coordinate MHC class II expression.Mol Immunol. 2006 Feb;43(5):395-409. doi: 10.1016/j.molimm.2005.03.008. Epub 2005 Apr 12. Mol Immunol. 2006. PMID: 16337482
-
Functional complementation of major histocompatibility complex class II regulatory mutants by the purified X-box-binding protein RFX.Mol Cell Biol. 1994 Oct;14(10):6839-47. doi: 10.1128/mcb.14.10.6839-6847.1994. Mol Cell Biol. 1994. PMID: 7935401 Free PMC article.
-
Molecular genetics of the Bare lymphocyte syndrome.Rev Immunogenet. 2000;2(2):267-82. Rev Immunogenet. 2000. PMID: 11258423 Review.
-
Lessons from the bare lymphocyte syndrome: molecular mechanisms regulating MHC class II expression.Immunol Rev. 2000 Dec;178:148-65. doi: 10.1034/j.1600-065x.2000.17813.x. Immunol Rev. 2000. PMID: 11213800 Review.
Cited by
-
A Novel RFXANK Mutation in a Chinese Child With MHC II Deficiency: Case Report and Literature Review.Open Forum Infect Dis. 2020 Jul 24;7(8):ofaa314. doi: 10.1093/ofid/ofaa314. eCollection 2020 Aug. Open Forum Infect Dis. 2020. PMID: 32875002 Free PMC article.
-
ERβ-selective agonist alleviates inflammation in a multiple sclerosis model via regulation of MHC II in microglia.Am J Transl Res. 2019 Jul 15;11(7):4411-4424. eCollection 2019. Am J Transl Res. 2019. PMID: 31396345 Free PMC article.
-
The 752delG26 mutation in the RFXANK gene associated with major histocompatibility complex class II deficiency: evidence for a founder effect in the Moroccan population.Eur J Pediatr. 2010 Sep;169(9):1069-74. doi: 10.1007/s00431-010-1179-6. Epub 2010 Apr 23. Eur J Pediatr. 2010. PMID: 20414676
-
Promoter-specific functions of CIITA and the MHC class II enhanceosome in transcriptional activation.EMBO J. 2002 Mar 15;21(6):1379-88. doi: 10.1093/emboj/21.6.1379. EMBO J. 2002. PMID: 11889043 Free PMC article.
-
Nucleosome eviction from MHC class II promoters controls positioning of the transcription start site.Nucleic Acids Res. 2009 May;37(8):2514-28. doi: 10.1093/nar/gkp116. Epub 2009 Mar 5. Nucleic Acids Res. 2009. PMID: 19264803 Free PMC article.
Publication types
MeSH terms
Substances
Associated data
- Actions
- Actions
- Actions
- Actions
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials